Novo Nordisk aims to hire 1,000 in emerging markets

Novo Nordisk ($NVO) has big hopes for emerging markets--and big plans for hiring enough people to turn those hopes into reality. The Danish company plans to hire 1,000 new employees over the next two years, to carry its diabetes treatments to Colombia, Egypt, Ukraine, Malaysia, Indonesia, and, especially, Vietnam. Report

Suggested Articles

Stephen Hahn, an oncologist who served as the chief medical officer for the MD Anderson Cancer Center, has secured Senate confirmation as FDA head.

As BMS searches for bright spots in its Opdivo-chemo combo fail from June, it’s zeroing in on squamous lung cancer patients who seemed to benefit.

The FDA's ad watchdog served its most serious violation to Alkermes Wednesday—and it took the unusual step of announcing that violation to the world.